Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties

Dreger, P.; Michallet, M.; Bosman, P.; Dietrich, S.; Sobh, M.; Boumendil, A.; Nagler, A.; Scheid, C.; Cornelissen, J.; Niederwieser, D.; Muller, L.; Vandenberghe, E.; Scortechini, I.; Schoemans, H.; Andersen, N. S.; Finke, J.; Russo, D.; Ljungman, P.; Passweg, J.; van Gelder, M.; Durakovic, N.; Labussiere-Wallet, H.; Berg, T.; Wulf, G.; Bethge, W.; Bunjes, D.; Stilgenbauer, S.; Canepari, M. E.; Schaap, M.; Fox, C. P.; Kroger, N.; Montoto, S.; Schetelig, J.